Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

SIMPLE SUMMARY: Multiple myeloma is a cancer that remains incurable. Among the many therapies under evaluation, antibodies can be used as vehicles to target and deliver toxic radiation to the tumour cells. Our objective was therefore to investigate the potential of targeted alpha therapy, combining...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Gouard, Sébastien, Maurel, Catherine, Marionneau-Lambot, Séverine, Dansette, Delphine, Bailly, Clément, Guérard, François, Chouin, Nicolas, Haddad, Ferid, Alliot, Cyril, Gaschet, Joëlle, Eychenne, Romain, Kraeber-Bodéré, Françoise, Chérel, Michel
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564412/
https://ncbi.nlm.nih.gov/pubmed/32971984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092721
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados